美容医学市场 - 按类型（手术程序、非手术程序）、产品（基于能源、非基于能源）、性别（男性、女性）、最终用途（医院、美容中心和医疗水疗中心、皮肤科诊所） - 全球预测（2024 - 2032）

在治疗和设备创新以及简化审批的推动下，2024 年至 2032 年间，全球美容医学市场规模将达到 12% 的复合年增长率。微创手术、先进雷射技术和改进的注射剂等进步正在提高治疗效果和患者满意度。此外，加快的监管流程正在促进创新更快进入市场并扩大治疗选择。这些发展满足了消费者不断增长的期望，吸引了更多的从业者和投资者，透过为全球美学增强提供更安全、更有效的解决方案来促进市场成长。

例如，2024 年 6 月，着名的开放取用出版商 PeerJ 与美容医学科学学会 Agora 合作，推出了美容与再生医学中心。此次合作旨在促进这些领域的创新研究和实际应用。它可以吸引更多的投资，刺激新程序的开发，并加强科学基础，从而扩大市场的能力并吸引全世界的从业者和患者。

美容医学行业根据类型、产品、性别、最终用途和地区进行细分。

由于雷射、射频和超音波等设备的技术创新，到 2032 年，基于能源的细分市场将显着成长。这些技术为嫩肤、塑身和除毛提供了有效的解决方案，满足了对非侵入性和微创治疗日益增长的需求。皮肤科医生和整容外科医生越来越多地采用这些基于能量的设备，突显了它们的临床疗效和患者满意度。随着不断的创新提高治疗效果，以能量为基础的细分市场将主导美容医学市场，解决全球多样化的美容问题。

由于患者对专业护理和个人化治疗的偏好不断增加，到 2032 年，皮肤科诊所领域将取得显着进展。这些诊所提供各种美容手术，如雷射治疗、注射和嫩肤治疗，满足不同的美学需求。消费者对皮肤科医师的专业知识和治疗方案的技术进步的信任不断增强，进一步提升了该细分市场的地位。随着对美容的需求不断上升，皮肤科诊所将在塑造市场成长轨迹方面发挥关键作用。

在可支配收入增加、美容手术意识提高和医疗基础设施进步的推动下，亚太地区美容医学行业份额从 2024 年到 2032 年将实现大幅复合年增长率。中国、日本和韩国等国家是这一成长的主要贡献者，这得益于不断增长的老年人口以及对美丽和健康的文化重视。该地区不断扩大的医疗旅游业进一步巩固了其市场地位。随着对非侵入性手术的需求上升，亚太地区在美容医学市场的主导地位将在未来几年得到巩固。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 提高对美容程序的认识
    • 与医疗美容设备相关的技术进步
    • 肥胖盛行率上升
    • 越来越多采用非侵入性手术
  • 产业陷阱与挑战
    • 与美容手术相关的高成本
    • 缺乏报销和严格的监管环境
• 成长潜力分析
• 技术景观
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 外科
• 非手术

第 6 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 基于能源
  • 雷射美容仪
  • 基于射频 (RF) 的美容设备
  • 光美容仪
  • 超音波美容仪
  • 其他能源产品
• 非能源型
  • 肉毒桿菌毒素
  • 真皮填充剂
  • 植入物
    • 脸部植入物
    • 乳房植入物
    • 其他植入物
  • 其他非能源产品

第 7 章：市场估计与预测：按性别划分，2021 - 2032 年

• 主要趋势
• 男性
  • 18岁及以下
  • 19-34岁
  • 35-50岁
  • 51-64岁
  • 65岁以上
• 女性
  • 18岁及以下
  • 19-34岁
  • 35-50岁
  • 51-64岁
  • 65岁以上

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 美容中心及医疗水疗中心
• 皮肤科诊所
• 主页设定

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 马来西亚
  • 新加坡
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 中东和非洲其他地区

第 10 章：公司简介

• Apax Partners
• Boston Scientific Corporation
• Bausch Health Companies Inc
• El.En. S.p.A.
• GC Aesthetics plc
• Huadong Medicine Co., Ltd.
• Johnson & Johnson
• Merz Pharma
• Sciton, Inc.
• SharpLight Technologies Inc.
• Sisram Medical Ltd
• Vitruvian Partners LLP

Global Aesthetic Medicine Market size will record a 12% CAGR between 2024 and 2032, driven by innovations in treatments and devices coupled with streamlined approvals. Advances such as minimally invasive procedures, advanced laser technologies, and improved injectables are enhancing treatment efficacy and patient satisfaction. Furthermore, expedited regulatory processes are facilitating quicker market entry for innovations and expanding treatment options. These developments meet rising consumer expectations and attract more practitioners and investors, fostering market growth by offering safer, more effective solutions for aesthetic enhancements globally.

For instance, in June 2024, PeerJ, an acclaimed Open Access publisher, partnered with Agora, the Scientific Society of Aesthetic Medicine, and launched the Aesthetic and Regenerative Medicine Hub. This collaboration aims to foster innovative research and practical applications in these fields. It may attract more investment, spur the development of new procedures, and strengthen scientific foundations, thereby expanding the market's capabilities and appeal to both practitioners and patients worldwide.

The aesthetic medicine industry is segmented based on type, product, gender, end-use, and region.

The energy-based segment will see a notable surge by 2032 due to technological innovations in devices like lasers, radiofrequency, and ultrasound. These technologies offer effective solutions for skin rejuvenation, body contouring, and hair removal, catering to a growing demand for non-invasive and minimally invasive treatments. Increasing adoption of these energy-based devices by dermatologists and cosmetic surgeons underscores their clinical efficacy and patient satisfaction. With ongoing innovations enhancing treatment outcomes, the energy-based segment will dominate the aesthetic medicine market in addressing diverse aesthetic concerns globally.

The dermatology clinics segment will amass remarkable gains by 2032, owing to increasing patient preference for specialized care and personalized treatments. These clinics offer a wide range of cosmetic procedures, such as laser treatments, injectables, and skin rejuvenation therapies, catering to diverse aesthetic needs. Growing consumer trust in dermatologists' expertise and technological advancements in treatment options further boost this segment's prominence. As the demand for aesthetic enhancements continues to rise, dermatology clinics will play a pivotal role in shaping the market's growth trajectory.

Asia Pacific aesthetic medicine industry share will achieve a substantial CAGR from 2024 to 2032, fueled by rising disposable incomes, increasing awareness of aesthetic procedures, and advancing healthcare infrastructure. Countries like China, Japan, and South Korea are key contributors to this growth, supported by a growing elderly population and cultural emphasis on beauty and wellness. The region's expanding medical tourism sector further bolsters its market position. As demand for non-invasive procedures rises, Asia Pacific's prominence in the aesthetic medicine market will solidify in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing awareness regarding aesthetic procedures
    • 3.2.1.2 Technological advancements associated with medical aesthetic devices
    • 3.2.1.3 Rising prevalence of obesity
    • 3.2.1.4 Increasing adoption of non-invasive procedures
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with aesthetic procedures
    • 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn, Units)

• 5.1 Key trends
• 5.2 Surgical
• 5.3 Non-surgical

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn, Units)

• 6.1 Key trends
• 6.2 Energy-based
  • 6.2.1 Laser-based aesthetic device
  • 6.2.2 Radiofrequency (RF)-based aesthetic device
  • 6.2.3 Light-based aesthetic device
  • 6.2.4 Ultrasound aesthetic device
  • 6.2.5 Other energy-based products
• 6.3 Non energy-based
  • 6.3.1 Botulinum toxin
  • 6.3.2 Dermal fillers
  • 6.3.3 Implants
    • 6.3.3.1 Facial implants
    • 6.3.3.2 Breast implants
    • 6.3.3.3 Other implants
  • 6.3.4 Others non energy-based products

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Male
  • 7.2.1 18 years and below
  • 7.2.2 19-34 years
  • 7.2.3 35-50 years
  • 7.2.4 51-64 years
  • 7.2.5 65 years and above
• 7.3 Female
  • 7.3.1 18 years and below
  • 7.3.2 19-34 years
  • 7.3.3 35-50 years
  • 7.3.4 51-64 years
  • 7.3.5 65 years and above

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Beauty centers and medical spas
• 8.5 Dermatology clinics
• 8.6 Home settings

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn, Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Malaysia
  • 9.4.7 Singapore
  • 9.4.8 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Apax Partners
• 10.2 Boston Scientific Corporation
• 10.3 Bausch Health Companies Inc
• 10.4 El.En. S.p.A.
• 10.5 GC Aesthetics plc
• 10.6 Huadong Medicine Co., Ltd.
• 10.7 Johnson & Johnson
• 10.8 Merz Pharma
• 10.9 Sciton, Inc.
• 10.10 SharpLight Technologies Inc.
• 10.11 Sisram Medical Ltd
• 10.12 Vitruvian Partners LLP